文献速递其他结缔组织病自身炎症与 IgG4 相关病

炎症性肌病中以头下垂综合征和躯干前屈症为首发表现:一项回顾性研究

Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

该回顾性研究纳入2000至2021年诊断的27例以轴性肌无力(头下垂综合征和/或躯干前屈症)为首发表现的炎症性肌病患者,按首发症状年龄分为≤70岁组(16例)和>70岁组(11例),分析其临床特点与结局,并提出相应的诊断与管理方法。

要点

  • 27例患者中位首发年龄66.0岁,女性21例(77.8%),IBM与重叠肌炎各9例(各33.3%)。
  • 首发年龄≤70岁组16例中部分缓解9例(56.3%)、完全缓解1例(6.3%)、头下垂/躯干前屈消退3例(18.8%)。
  • 首发年龄>70岁组11例中IBM 8例(72.7%),部分缓解5例(45.5%)、病情稳定6例(54.5%),无完全缓解及头下垂/躯干前屈消退。

核心结论

  • 以头下垂综合征/躯干前屈症为首发表现的炎症性肌病患者可按首发症状年龄分为两组,两组在临床和结局上各有特点。
  • 作者提出针对性的诊断与管理方法以预防长期并发症。

研究设计与样本

  • 回顾性研究,纳入2000至2021年诊断的炎症性肌病患者,主要纳入标准为以轴性肌无力(头下垂综合征/躯干前屈症)为首发表现,共27例。

主要发现

  • 27例患者中位(IQR)首发症状年龄66.0岁(55.5-75.0),女性21例(77.8%)。
  • 诊断构成:IBM 9例(33.3%)、重叠肌炎9例(33.3%)、DM 5例(18.5%)、免疫检查点抑制剂相关肌炎2例(7.4%)、局灶性肌炎1例(3.7%)、伴抗Hu抗体肌炎1例(3.7%)。
  • 首发年龄≤70岁组16例(59.3%),包括全部DM患者及8/9例重叠肌炎患者(88.9%)。
  • ≤70岁组部分缓解9/16例(56.3%)、完全缓解1/16例(6.3%)、头下垂/躯干前屈消退3/16例(18.8%)。
  • >70岁组11例中IBM 8例(72.7%),部分缓解5/11例(45.5%)、病情稳定6/11例(54.5%),无完全缓解及头下垂/躯干前屈消退。

临床怎么用

  • 作者提出针对以头下垂综合征/躯干前屈症为首发表现的炎症性肌病的适应性诊断与管理方法,以预防长期并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Inaugural axial muscle involvement, defined as dropped head syndrome (DHS) and/or camptocormia (CC), is poorly described in inflammatory myopathies (IM). This study aimed to further characterize IM patients with inaugural DHS/CC, their outcome and care management. METHODS: This retrospective study included IM patients diagnosed between 2000 and 2021. The main inclusion criterion was IM revealed by axial muscle deficit (DHS/CC). RESULTS: Twenty-seven patients were included; median (IQR) age at first symptoms was 66.0 years (55.5-75.0); 21 were female (77.8%). There were nine IBM, 33.3%, nine overlap myositis (OM, 33.3%), five DM, 18.5%, two immune checkpoint inhibitor-related myositis (7.4%), one focal myositis (3.7%) and one myositis with anti-Hu antibodies (3.7%). Age at first symptoms was ≤70 years in 16 patients (59.3%), including all DM patients and 8/9 OM patients (88.9%). In this group, partial remission of the disease was obtained in 9/16 (56.3%) and complete remission in 1/16 patients (6.3%); regression of DHS/CC was achieved in 3/16 patients (18.8%). Conversely, in the group of 11 patients aged >70 years at first symptoms, there were eight IBM (72.7%). Partial remission was obtained in 5/11 patients (45.5%), the disease was stable in 6/11 patients (54.5%); no complete remission was obtained nor regression of DHS/CC. CONCLUSION: The analysis of IM patients with inaugural DHS/CC delineates two groups of patients according to the age at first symptoms in terms of clinical and outcome specificities, and proposes an adapted diagnostic and care management approach to prevent long-term complications.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Robert M, Lessard LER, Bouhour F, et al. Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study. Rheumatology (Oxford). 2024. PMID: 37462538. doi:10.1093/rheumatology/kead347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。